Annual Cash & Cash Equivalents
$3.09 M
-$8.15 M-72.49%
June 30, 2024
Summary
- As of February 24, 2025, ANEB annual cash & cash equivalents is $3.09 million, with the most recent change of -$8.15 million (-72.49%) on June 30, 2024.
- During the last 3 years, ANEB annual cash & cash equivalents has fallen by -$16.89 million (-84.52%).
- ANEB annual cash & cash equivalents is now -84.52% below its all-time high of $19.99 million, reached on June 30, 2021.
Performance
ANEB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$15.00 M
+$13.59 M+968.12%
December 31, 2024
Summary
- As of February 24, 2025, ANEB quarterly cash and cash equivalents is $15.00 million, with the most recent change of +$13.59 million (+968.12%) on December 31, 2024.
- Over the past year, ANEB quarterly cash and cash equivalents has stayed the same.
- ANEB quarterly cash and cash equivalents is now -24.95% below its all-time high of $19.99 million, reached on June 30, 2021.
Performance
ANEB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANEB Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -72.5% | 0.0% |
3 y3 years | -84.5% | 0.0% |
5 y5 years | +2.3% | 0.0% |
ANEB Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -84.5% | at low | -21.9% | +968.1% |
5 y | 5-year | -84.5% | +2.3% | -24.9% | +968.1% |
alltime | all time | -84.5% | +2.3% | -24.9% | +968.1% |
Anebulo Pharmaceuticals Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $15.00 M(+968.1%) |
Sep 2024 | - | $1.40 M(-54.6%) |
Jun 2024 | $3.09 M(-72.5%) | $3.09 M(-39.9%) |
Mar 2024 | - | $5.15 M(-22.5%) |
Dec 2023 | - | $6.64 M(-22.0%) |
Sep 2023 | - | $8.52 M(-24.2%) |
Jun 2023 | $11.25 M | $11.25 M(-20.6%) |
Mar 2023 | - | $14.16 M(-13.4%) |
Dec 2022 | - | $16.36 M(-14.9%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $19.21 M(+32.1%) |
Jun 2022 | $14.55 M(-27.2%) | $14.55 M(-12.1%) |
Mar 2022 | - | $16.55 M(-8.1%) |
Dec 2021 | - | $18.01 M(-6.2%) |
Sep 2021 | - | $19.21 M(-3.9%) |
Jun 2021 | $19.99 M(+560.7%) | $19.99 M(+504.3%) |
Mar 2021 | - | $3.31 M(+33.4%) |
Dec 2020 | - | $2.48 M |
Jun 2020 | $3.02 M | - |
FAQ
- What is Anebulo Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Anebulo Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Anebulo Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ANEB is $3.09 M
What is the all time high annual cash & cash equivalents for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual cash & cash equivalents is $19.99 M
What is Anebulo Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ANEB annual cash & cash equivalents has changed by -$8.15 M (-72.49%)
What is Anebulo Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANEB is $15.00 M
What is the all time high quarterly cash and cash equivalents for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly cash and cash equivalents is $19.99 M
What is Anebulo Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ANEB quarterly cash and cash equivalents has changed by $0.00 (0.00%)